JP6803002B2 - エーロゾルを加湿する加湿機 - Google Patents
エーロゾルを加湿する加湿機 Download PDFInfo
- Publication number
- JP6803002B2 JP6803002B2 JP2016555498A JP2016555498A JP6803002B2 JP 6803002 B2 JP6803002 B2 JP 6803002B2 JP 2016555498 A JP2016555498 A JP 2016555498A JP 2016555498 A JP2016555498 A JP 2016555498A JP 6803002 B2 JP6803002 B2 JP 6803002B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- aerosol
- intermediate chamber
- passage
- inlet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000443 aerosol Substances 0.000 title claims description 208
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 217
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 26
- 239000012528 membrane Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 15
- 239000002245 particle Substances 0.000 description 36
- 239000003580 lung surfactant Substances 0.000 description 32
- 239000013543 active substance Substances 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 238000012387 aerosolization Methods 0.000 description 11
- 239000007789 gas Substances 0.000 description 10
- 239000012159 carrier gas Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 5
- 150000003904 phospholipids Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 4
- 239000000596 artificial lung surfactant Substances 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- -1 phospholipids Chemical class 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 3
- 102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 description 3
- 108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 2
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229940066294 lung surfactant Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000010399 physical interaction Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- PAZGBAOHGQRCBP-ZCXUNETKSA-N 1-Palmitoyl-2-oleoylglycero-3-phosphoglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC PAZGBAOHGQRCBP-ZCXUNETKSA-N 0.000 description 1
- 208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008589 Choking Diseases 0.000 description 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 101000612671 Homo sapiens Pulmonary surfactant-associated protein C Proteins 0.000 description 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 1
- 208000032571 Infant acute respiratory distress syndrome Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 206010028974 Neonatal respiratory distress syndrome Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 description 1
- 229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 description 1
- 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 1
- 102000007615 Pulmonary Surfactant-Associated Protein A Human genes 0.000 description 1
- 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 description 1
- 108010007127 Pulmonary Surfactant-Associated Protein D Proteins 0.000 description 1
- 108010041520 Pulmonary Surfactant-Associated Proteins Proteins 0.000 description 1
- 102000000528 Pulmonary Surfactant-Associated Proteins Human genes 0.000 description 1
- 102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 description 1
- 102100027845 Pulmonary surfactant-associated protein D Human genes 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 108010031254 Venticute Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229960003728 ciclesonide Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940092456 curosurf Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940112141 dry powder inhaler Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 102000047087 human SFTPC Human genes 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940026289 infasurf Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- GUKVIRCHWVCSIZ-ROKJYLDNSA-N lusupultide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)C1=CN=CN1 GUKVIRCHWVCSIZ-ROKJYLDNSA-N 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000002652 newborn respiratory distress syndrome Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 description 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 description 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- MNDBXUUTURYVHR-UHFFFAOYSA-N roflumilast Chemical compound FC(F)OC1=CC=C(C(=O)NC=2C(=CN=CC=2Cl)Cl)C=C1OCC1CC1 MNDBXUUTURYVHR-UHFFFAOYSA-N 0.000 description 1
- 229960002586 roflumilast Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229960003310 sildenafil Drugs 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940080796 surfaxin Drugs 0.000 description 1
- 229940063649 survanta Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0808—Condensation traps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1075—Preparation of respiratory gases or vapours by influencing the temperature
- A61M16/109—Preparation of respiratory gases or vapours by influencing the temperature the humidifying liquid or the beneficial agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/142—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase with semi-permeable walls separating the liquid from the respiratory gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
- A61M16/16—Devices to humidify the respiration air
- A61M16/162—Water-reservoir filling system, e.g. automatic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
- B05B1/02—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape
- B05B1/06—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to produce a jet, spray, or other discharge of particular shape or nature, e.g. in single drops, or having an outlet of particular shape in annular, tubular or hollow conical form
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B1/00—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means
- B05B1/24—Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means incorporating means for heating the liquid or other fluent material, e.g. electrically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0883—Circuit type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/105—Filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/0488—Surfactant, e.g. for the lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
- A61M2205/125—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with incorporated filters
- A61M2205/126—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with incorporated filters with incorporated membrane filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
- A61M2205/127—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with provisions for heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
- A61M2205/128—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with incorporated valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/3653—General characteristics of the apparatus related to heating or cooling by Joule effect, i.e. electric resistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/366—General characteristics of the apparatus related to heating or cooling by liquid heat exchangers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
- A61M2205/7536—General characteristics of the apparatus with filters allowing gas passage, but preventing liquid passage, e.g. liquophobic, hydrophobic, water-repellent membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/11—Laminar flow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B12/00—Arrangements for controlling delivery; Arrangements for controlling the spray area
- B05B12/08—Arrangements for controlling delivery; Arrangements for controlling the spray area responsive to condition of liquid or other fluent material to be discharged, of ambient medium or of target ; responsive to condition of spray devices or of supply means, e.g. pipes, pumps or their drive means
- B05B12/10—Arrangements for controlling delivery; Arrangements for controlling the spray area responsive to condition of liquid or other fluent material to be discharged, of ambient medium or of target ; responsive to condition of spray devices or of supply means, e.g. pipes, pumps or their drive means responsive to temperature or viscosity of liquid or other fluent material discharged
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Air Humidification (AREA)
- Nozzles (AREA)
- Medicinal Preparation (AREA)
Description
Claims (17)
- エーロゾルを加湿するように構成された加湿機であって、
エーロゾルを加湿するために使用される水を収容した第1の水コンパートメント(100)と、
前記エーロゾルを加湿するために使用される水を収容した第2の水コンパートメント(300)と、
前記第1及び第2の水コンパートメント(100、300)の間に位置し、エーロゾル入口(210)及びエーロゾル出口(220)を備え、加湿される前記エーロゾルが通過する通路(230)の第1の境界面を提供する、中間チャンバ(200)と、
水蒸気に対しては透過性であって液体水に対しては不透過性であり、前記第1の水コンパートメント(100)と前記中間チャンバ(200)との間に位置し、一区画が前記通路の第2の境界面を提供する、第1の層(10)と、
水蒸気に対しては透過性であって液体水に対しては不透過性であり、前記第2の水コンパートメント(300)と前記中間チャンバ(200)との間に位置し、一区画が前記第2の境界面とは反対側にある前記通路(230)の第3の境界面を提供する、第2の層(20)と、を備え、
前記中間チャンバが、前記中間チャンバ(200)の横面からその内部へとそれぞれ突出する少なくとも二つの突出部(240、250、260)を備え、前記少なくとも二つの突出部(240、250、260)が、前記第1の境界面の一部であると共に、前記通路(230)が前記少なくとも二つの突出部の間で前記中間チャンバ内部の蛇行パターンを辿るように前記中間チャンバ(200)の内部へと突出しており、
加湿される前記エーロゾルが前記通路(230)に入る前記エーロゾル入口にノズル(500)が設けられ、前記ノズル(500)が前記エーロゾルの流れ方向で増加する断面を有し、前記ノズルが、圧力パルスによって励起されるように構成された少なくとも一つの励起可能なメンブレン(520)を内壁として備える、加湿機。 - 前記中間チャンバ(200)が実質的に円筒状の形状を有し、前記エーロゾル入口(210)及び前記エーロゾル出口(220)が前記中間チャンバの前記横面に位置する、請求項1に記載の加湿機。
- 前記通路を通過する前記エーロゾルが、前記中間チャンバの前記実質的に円筒状の形状によって規定される軸線方向に対して実質的に垂直に流れるように、前記第1の境界面、前記第2の境界面、及び前記第3の境界面によって境界を定められた前記通路が、前記中間チャンバ内で位置する、請求項2に記載の加湿機。
- 前記第1の層(10)が前記第2の層(20)に実質的に平行に配置されている、請求項1から3のいずれか一項に記載の加湿機。
- 前記エーロゾル出口(220)を出る前記エーロゾルが、前記エーロゾル入口(210)に入る前記エーロゾルの流れ方向と実質的に反対の流れ方向を有するように、前記エーロゾル入口(210)、前記通路(230)、及び前記エーロゾル出口(220)が配置される、請求項1から4のいずれか一項に記載の加湿機。
- 前記第1の層(10)が前記備えられた突出部(240、250、260)の第1の支持面上にあり、前記第2の層(20)が、前記第1の支持面とは反対側で前記少なくとも一つの突出部の第2の支持面上にあり、前記第1及び第2の層が、前記中間チャンバの軸線方向で、前記通路の隣接した区画を相互から封止する、請求項1に記載の加湿機。
- 前記中間チャンバ(200)が、前記通路内への呼吸空気の入口用に構成された第2の入口(270)を前記通路に備える、請求項1から6のいずれか一項に記載の加湿機。
- 前記通路内における前記エーロゾルの流れの方向で、前記エーロゾル入口(210)の後に前記第2の入口(270)が位置する、請求項7に記載の加湿機。
- 前記第1の水コンパートメント(100)及び前記第2の水コンパートメント(300)がそれぞれ、対応するコンパートメント内の前記水を加熱する加熱ユニット(130、330)を備える、請求項1から8のいずれか一項に記載の加湿機。
- 前記第1及び第2の水コンパートメント(100、300)を通して水を循環させる水回路(400)を更に備える、請求項1から8のいずれか一項に記載の加湿機。
- 前記水回路が、前記水回路を通して前記水を給送するポンプと、前記水を加熱するように構成された熱交換器と、を備える、請求項10に記載の加湿機。
- 対応する水コンパートメント内を循環する前記水を案内し、前記第1及び第2の層それぞれに対する更なる支持面を構築する突起(140、340)を、各水コンパートメント(100、300)が備える、請求項1から11のいずれか一項に記載の加湿機。
- 前記中間チャンバ(200)が前記通路内において、前記中間チャンバの前記横面に位置する、凝縮された液体を除去するための開口部(280)を備える、請求項2から12のいずれか一項に記載の加湿機。
- 前記ノズルが円錐形状を有する、請求項1に記載の加湿機。
- 前記ノズル(500)の開放角が、5度から15度の間である、請求項14に記載の加湿機。
- 前記第1及び第2の水コンパートメント(100、300)がそれぞれ実質的に円筒形状を有し、前記第1及び第2の水コンパートメント(100、300)がそれぞれ、前記横面の一方の側に水入口(110)と、前記横面の他方の側に水出口(120)と、を備える、請求項1から15のいずれか一項に記載の加湿機。
- 前記円筒形状の中間チャンバの軸線方向に垂直な面(A)に対して鏡面対称であることを特徴とする、請求項1から16のいずれか一項に記載の加湿機。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14157788.2 | 2014-03-05 | ||
EP14157788 | 2014-03-05 | ||
PCT/EP2015/054240 WO2015132172A1 (en) | 2014-03-05 | 2015-03-02 | Humidifier for humidifying an aerosol |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017511170A JP2017511170A (ja) | 2017-04-20 |
JP6803002B2 true JP6803002B2 (ja) | 2020-12-23 |
Family
ID=50230946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016555498A Active JP6803002B2 (ja) | 2014-03-05 | 2015-03-02 | エーロゾルを加湿する加湿機 |
Country Status (10)
Country | Link |
---|---|
US (1) | US11123513B2 (ja) |
EP (1) | EP3113823B1 (ja) |
JP (1) | JP6803002B2 (ja) |
KR (1) | KR102369135B1 (ja) |
CN (1) | CN106163600B (ja) |
AU (1) | AU2015226287B2 (ja) |
BR (1) | BR112016020393B1 (ja) |
ES (1) | ES2674797T3 (ja) |
RU (1) | RU2687776C2 (ja) |
WO (1) | WO2015132172A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106823087B (zh) * | 2017-03-23 | 2020-07-10 | 北京怡和嘉业医疗科技股份有限公司 | 气路组件、储液装置和呼吸机 |
EP3456371B1 (en) | 2017-09-18 | 2020-04-08 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for administering a humidified aerosol to a patient interface |
WO2021243000A1 (en) * | 2020-05-28 | 2021-12-02 | Minnetronix Neuro, Inc. | Filtering systems and filtering manifolds for use with filtering systems |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3871373A (en) * | 1972-10-30 | 1975-03-18 | Richard R Jackson | Humidifying gas |
DE2929584A1 (de) * | 1979-07-21 | 1981-02-05 | Draegerwerk Ag | Feuchtigkeitsaustauscher in einrichtungen fuer die atmung |
US4861523A (en) * | 1987-07-13 | 1989-08-29 | Beran Anthony V | Humidification in respiratory systems |
US4829997A (en) * | 1988-02-18 | 1989-05-16 | University Of Victoria | Portable heat exchanger for inhalation rewarming |
US4910384A (en) | 1988-08-23 | 1990-03-20 | The Kendall Company | Position independent humidifier apparatus |
NZ226784A (en) * | 1988-09-29 | 1992-10-28 | Fisher & Paykel | Gas humidifier with microporous wall |
US4943704A (en) * | 1989-02-06 | 1990-07-24 | Ryder International Corporation | Humidifier apparatus |
ES2146580T3 (es) | 1990-10-17 | 2000-08-16 | Liposome Co Inc | Agente tensioactivo sintetico para los pulmones. |
DE4418936A1 (de) | 1994-05-31 | 1996-02-08 | Byk Gulden Lomberg Chem Fab | Polypeptid |
JP3478623B2 (ja) | 1994-12-28 | 2003-12-15 | ジャパンゴアテックス株式会社 | 加湿装置 |
AUPN344095A0 (en) * | 1995-06-08 | 1995-07-06 | Rescare Limited | A humidifier |
PT877602E (pt) | 1996-01-24 | 2002-07-31 | Byk Gulden Lomberg Chem Fab | Processo para o fabrico de composicoes de surfactantes pulmonares em po |
JPH1015070A (ja) * | 1996-06-28 | 1998-01-20 | Japan Gore Tex Inc | 医療用ガス加湿器および医療用ガス供給装置 |
JP3748466B2 (ja) * | 1996-08-23 | 2006-02-22 | 株式会社メトラン | 加湿調整ユニット及び加湿調整ユニットの製造方法 |
US8336545B2 (en) * | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
MXPA02010884A (es) * | 2000-05-05 | 2003-03-27 | Aerogen Ireland Ltd | Aparato y metodo para el suministro de medicamentos al sistema respiratorio. |
JP3547122B2 (ja) | 2000-06-06 | 2004-07-28 | 大陽東洋酸素株式会社 | 医療用ガス加湿器 |
US7708013B2 (en) * | 2000-12-08 | 2010-05-04 | Vapotherm, Inc. | Apparatus and method for delivering water vapor to a gas |
ES2300568T3 (es) * | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
US7476212B2 (en) | 2003-06-12 | 2009-01-13 | Michael Spearman | Medical gas humidification system |
US8803044B2 (en) * | 2003-11-05 | 2014-08-12 | Baxter International Inc. | Dialysis fluid heating systems |
US7753991B2 (en) * | 2004-07-30 | 2010-07-13 | Kertzman Systems, Inc. | Water transport method and assembly including a thin film membrane for the addition or removal of water from gases or liquids |
DE102005016100B3 (de) | 2005-04-08 | 2006-10-26 | Altana Pharma Ag | Vorrichtung zur Dosierung und Trockenvernebelung |
US8079574B2 (en) * | 2007-05-16 | 2011-12-20 | ZenPure Corp. | Membrane based contactor module for mass and heat transfer |
US8550075B2 (en) * | 2007-06-28 | 2013-10-08 | Resmed Limited | Removable and/or replaceable humidifier |
EP2337600B1 (en) * | 2008-09-26 | 2019-09-18 | Stamford Devices Limited | Supplemental oxygen delivery system |
KR20120023668A (ko) * | 2009-04-23 | 2012-03-13 | 니코메드 게엠베하 | 큰 부피의 건조 분말의 분무를 위한 개선된 장치 |
US8479740B2 (en) * | 2009-11-23 | 2013-07-09 | Covidien Lp | Airway devices with integral humidification |
US9693955B2 (en) * | 2010-08-23 | 2017-07-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Humidified particles comprising a therapeutically active substance |
US10213573B2 (en) * | 2011-12-22 | 2019-02-26 | Resmed Limited | Humidifiers for respiratory apparatus |
SG11201405061VA (en) * | 2012-03-09 | 2014-11-27 | Vectura Gmbh | Mixing channel for an inhalation device and inhalation device |
-
2015
- 2015-03-02 WO PCT/EP2015/054240 patent/WO2015132172A1/en active Application Filing
- 2015-03-02 US US15/123,559 patent/US11123513B2/en active Active
- 2015-03-02 AU AU2015226287A patent/AU2015226287B2/en active Active
- 2015-03-02 ES ES15706836.2T patent/ES2674797T3/es active Active
- 2015-03-02 JP JP2016555498A patent/JP6803002B2/ja active Active
- 2015-03-02 RU RU2016134232A patent/RU2687776C2/ru active
- 2015-03-02 KR KR1020167024328A patent/KR102369135B1/ko active IP Right Grant
- 2015-03-02 BR BR112016020393-3A patent/BR112016020393B1/pt active IP Right Grant
- 2015-03-02 EP EP15706836.2A patent/EP3113823B1/en active Active
- 2015-03-02 CN CN201580012110.2A patent/CN106163600B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
RU2687776C2 (ru) | 2019-05-16 |
WO2015132172A1 (en) | 2015-09-11 |
CN106163600A (zh) | 2016-11-23 |
US11123513B2 (en) | 2021-09-21 |
RU2016134232A3 (ja) | 2018-08-29 |
BR112016020393B1 (pt) | 2022-03-29 |
RU2016134232A (ru) | 2018-04-25 |
CN106163600B (zh) | 2019-03-22 |
KR20160125986A (ko) | 2016-11-01 |
KR102369135B1 (ko) | 2022-02-28 |
US20170072161A1 (en) | 2017-03-16 |
EP3113823B1 (en) | 2018-04-25 |
AU2015226287A1 (en) | 2016-09-15 |
ES2674797T3 (es) | 2018-07-04 |
BR112016020393A2 (ja) | 2017-08-15 |
JP2017511170A (ja) | 2017-04-20 |
EP3113823A1 (en) | 2017-01-11 |
AU2015226287B2 (en) | 2019-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2608769B1 (en) | Humidified particles comprising a therapeutically active substance | |
US20060078506A1 (en) | Methods, systems and devices for noninvasive pulmonary delivery | |
Mazela et al. | Aerosol delivery to ventilated newborn infants: historical challenges and new directions | |
US20060120968A1 (en) | Methods, systems and devices for delivery of pulmonary surfactants | |
EP1796770A1 (en) | Methods, systems and devices for noninvasive pulmonary delivery | |
JP6803002B2 (ja) | エーロゾルを加湿する加湿機 | |
Yeates | Surfactant aerosol therapy for nRDS and ARDS | |
KR102628433B1 (ko) | 가습 에어로졸을 환자 인터페이스에 투여하는 장치 | |
Mazela | Aerosolization and nebulization | |
Donn et al. | Aerosolization and Nebulization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20161212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20161212 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180124 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190212 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190702 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191002 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200512 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200911 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200911 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200925 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20200929 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201027 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20201104 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201112 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20201104 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6803002 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |